The significance of anaemia in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

Kardiologia Polska

Volumn 69, Issue 1, 2011, Pages 33-39

  Bolińska, Swietłana ^a   Sobkowicz, Bozena ^a   Zaniewska, Justyna ^a   Chlebińska, Iwona ^a   Boliński, Jerzy ^b   Milewski, Robert ^a   Tycińska, Agnieszka ^a   Musiał, Włodzimierz ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b General Hospital   (Poland)

Author keywords

Anaemia; Primary percutaneous coronary intervention; ST elevation myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE MB; HEMOGLOBIN;

ABNORMAL LABORATORY RESULT; ADULT; AGED; ANEMIA; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; KIDNEY DYSFUNCTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; WORLD HEALTH ORGANIZATION;

EID: 79952210382     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Silverberg DS, Wexler D, Iaina A et al. The interaction between heart failure and other heart diseases, renal failure, and anemia. Semin Nephrol, 2006; 26: 296-306. (Pubitemid 44722449)
2. Valeur N, Nielsen OW, McMurray JJ et al. Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction. Eur J Heart Fail, 2006; 8: 577-584. (Pubitemid 44572960)
3. Schunkert H, Hense WH. A heart price to pay for anemia. Nephrol Dial Transplant, 2001; 16: 445-448.
4. McKechnie RS, Smith D, Montoye C et al. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation, 2004; 110: 271-277. (Pubitemid 38955496)
5. Al Falluji N, Lawrence-Nelson J, Kostis J et al. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. Am Heart J, 2002; 144: 636-641.
6. Moscucci M, Fox KA, Cannon CP et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J, 2003; 24: 1815-1823.
7. Rao SV. Implications of bleeding and blood transfusion in percutaneous coronary intervention. Rev Cardiovasc Stone Med, 2007; 8 (suppl. 3): 18-26.
8. Bassand JP. Impact of anaemia, bleeding and transfusions in acute coronary syndromes: a shift in the paradigm. Eur Heart J, 2007; 28: 1273-1274.
9. World Health Organization. Nutritional anaemias. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser, 1968; 405: 5-37.
10. Ganong WF ed. Dział VI: Kra̧żenie. Mechanizm reguluja̧cy układ sercowo-naczyniowy. In: Podstawy Fizjologii Lekarskiej. Wyd. Lekarskie PZWL, Warszawa 1994: 710-712.
11. Archbold RA, Balami D, Al-Hajiri A et al. Hemoglobin concentration is an independent determinant of heart failure in acute coronary syndromes: cohort analysis of 2310 patients. Am Heart J, 2006; 152: 1091-1095. (Pubitemid 44856713)
12. Giraldes R, Sabatine M, Morrow D et al. Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction. Am Heart J, 2009; 157: 517-524.
13. Lee PC. Kini AS. Ahsan C et al. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol, 2004; 44: 541-546. (Pubitemid 39078176)
14. Zeidman A, Fradin Z, Blecher A et al. Anemia as a risk factor for ischemic heart disease. Isr Med Assoc J, 2004; 6: 16-18. (Pubitemid 38094371)
15. Montalescot G, Dellongeville J, Van Bellee E et al. STEMI and NSTEMI: are they so different? One year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J, 2007; 28: 1409-1417.
16. Sabatine MS, Morrow D, Giugliano RI et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation, 2005; 111: 2042-2049.
17. Kozieradzka A, Kamiński K, Dobrzycki S. Usefulness of TIMI, Zwolle and CADILLAC risk scores for predicting five-year mortality in 30-day survivors of ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Eur Heart J, 2007; 28 (suppl. 1): 574.
18. Nikolsky E, Aymong ED, Halkin A et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol, 2004; 44: 547-553. (Pubitemid 39078177)
19. Greenberg G, Assali A, Vaknin-Assa H et al. Hematocrit level as a marker of outcome in ST-segment elevation myocardial infarction. Am J Cardiol, 2010; 105: 435-440.
20. Kruk M, Przyłuski J, Kalińczuk L et al. Clustering of admission hyperglycemia, impaired renal function and anemia and its impact on in-hospital outcomes in patients with ST-elevation myocardial infarction. Atherosclerosis, 2010; 209: 558-564.
21. Aronson D, Suleiman M, Agmon Y et al. Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. Eur Heart J, 2007; 11: 1289-1296. (Pubitemid 47355975)
22. Silverberg DS, Wexler D, Blum M et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol, 2000; 35: 1737-1744. (Pubitemid 30342851)
23. Nair D, Shlipak MG, Angeja B et al. Association of anemia with diastolic dysfunction among patients with coronary artery disease in the Heart and Soul Study. Am J Cardiol, 2005; 95: 332-336. (Pubitemid 40164535)
24. Levy WC. Anemia in Heart Failure. J Am Coll Cardiol, 2008; 5: 577-578.
25. Voors A; for the trialists. A single bolus of erythropoietin does not improve cardiac function after an acute myocardial infarction: results from the HEBE III trial. Oral communication at the 2010 ESC Congress Stockholm. http://www.escardio.org/about/press//press-releases/esc10-stockholm/pages/ hli-voors-hebe-iii-trial.aspx.